Rain Oncology Inc.
DelistedCIK 1724979fmd_16R145XB351R7G7JSWM11P5A44Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 15 periods
Latest annual · FY2022
Millions- Operating income
- (77)
- Net income
- (76)
- Free cash flow
- (63)
Latest quarter · Q3 FY2023
Millions- Operating income
- (8)
- Net income
- (7)
- Free cash flow
- (7)
Rain Oncology Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Operating income | -$77.1 million | -$51.5 million | 10-K 2023-03-09 · proof | |
| Net income | -$75.7 million | -$51.4 million | 10-K 2023-03-09 · proof | |
| Cash from operating activities | -$63.2 million | -$37.5 million | 10-K 2023-03-09 · proof | |
| Free cash flow | -$63.2 million | -$37.6 million | 10-K 2023-03-09 · proof | |
| Total assets | $135.2 million | $147.1 million | -8.1% | 10-K 2023-03-09 · proof |
| Total liabilities | $22.1 million | $16.6 million | +33.1% | 10-K 2023-03-09 · proof |
| Cash and cash equivalents | $62 million | $24.8 million | +150% | 10-K 2023-03-09 · proof |
- What was Rain Oncology Inc.'s operating income in fiscal 2022?
- Rain Oncology Inc. reported operating income of -$77.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$51.5 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Rain Oncology Inc.'s net income in fiscal 2022?
- Rain Oncology Inc. reported net income of -$75.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$51.4 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Rain Oncology Inc.'s cash from operating activities in fiscal 2022?
- Rain Oncology Inc. reported cash from operating activities of -$63.2 million for fiscal 2022 (the year ended Dec 31, 2022), against -$37.5 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Rain Oncology Inc.'s free cash flow in fiscal 2022?
- Rain Oncology Inc. reported free cash flow of -$63.2 million for fiscal 2022 (the year ended Dec 31, 2022), against -$37.6 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are Rain Oncology Inc.'s total assets?
- As of Dec 31, 2022, Rain Oncology Inc. reported total assets of $135.2 million, against $147.1 million a year earlier (-8.1%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are Rain Oncology Inc.'s total liabilities?
- As of Dec 31, 2022, Rain Oncology Inc. reported total liabilities of $22.1 million, against $16.6 million a year earlier (+33.1%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are Rain Oncology Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Rain Oncology Inc. reported cash and cash equivalents of $62 million, against $24.8 million a year earlier (+150%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1724979&period_type=annual&limit=5"Information only, not investment advice.